Novus Biologicals

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Novus Biologicals
Public company
IndustryBiotech, Life sciences
Founded1996
Headquarters
Centennial, Colorado
,
USA
ProductsAntibodies, kits, proteins, peptides, RNAi, inhibitors, ELISAs, slides and other research reagents
Websitewww.novusbio.com

Novus Biologicals is a biotech company based in Centennial, Colorado. The company develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Novus began as a company focused on providing research-grade antibodies for the scientific market. It was acquired by Bio-Techne in 2014.

Background[edit]

Founded in 1996, Novus Biologicals has developed more than 180,000 products,[1] ranging from antibodies to cell lysates and purification kits.[2]

In 2008, Novus became a limited liability company when Mainsail Partners invested in the company.[3] Novus Biologicals has reported double digit revenue growth every year since its inception, has been selected six years in a row to the Inc. (magazine) 5000 fastest-growing private companies in America,[4] and was on the 2009 list of Colorado Companies to Watch.[5]

In 2014, antibody and reagent supplier Bio-Techne, acquired Novus Biologicals for $60 million.[6] The acquisition was meant to provide scientists and doctors a broader selection of products in one location.

References[edit]

  1. ^ Business Week. Retrieved 23 November 2009. http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=51175657.
  2. ^ Oredigger 5 October 2009. https://www.scribd.com/doc/20649260/The-Oredigger-Issue-05-October-5-2009.
  3. ^ Mainsail Partners. Retrieved 24 November 2009. http://www.mainsailpartners.com/
  4. ^ "Novus Biologicals Company Profile" Inc. (magazine) Retrieved 10 November 2009. http://www.inc.com/profile/novus-biologicals.
  5. ^ "50 Colorado companies: Fueling the economic fire" ColoradoBIZ Magazine. 1 June 2009. http://www.cobizmag.com/articles/50-colorado-companies-fueling-the-economic-fire/page-5/.
  6. ^ "Bio-Techne Announces Agreement To Acquire Novus Biologicals". Bio-Techne (Press release). 2014-07-02. Retrieved 2015-04-25.

External links[edit]